What questions should I ask about my cancer pathology report
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Key Questions to Ask About Your Cancer Pathology Report
A pathology report is one of the most important documents in your cancer care—it describes what the pathologist found when examining your tissue sample. Here are the essential questions to ask your oncologist:
ABOUT THE DIAGNOSIS & TUMOR TYPE
-
"What type of cancer do I have, and what does that mean?"
- Make sure you understand the specific cancer type (e.g., adenocarcinoma, squamous cell, etc.)
- Ask how this type typically behaves and what it means for treatment options
-
"What is the grade of my cancer, and what does that tell us?"
- Grade (1-3 or low/intermediate/high) describes how abnormal the cells look
- Higher grades often grow faster and may require more aggressive treatment
- Ask what your grade means for your prognosis and treatment approach
-
"What stage is my cancer?"
- Stage describes how far the cancer has spread (TNM staging: Tumor size, Node involvement, Metastasis)
- This is critical for determining treatment intensity and options
ABOUT BIOMARKERS & MOLECULAR TESTING
-
"What biomarkers or genetic tests were done, and what do the results mean?"
- Examples: ER/PR status (breast cancer), HER2 status, EGFR mutations, BRAF mutations, MSI/MMR status, PD-L1 expression
- Ask specifically: "Do these results change my treatment options?"
- Understanding your biomarkers often opens doors to targeted therapies
-
"Are there any genetic mutations in my cancer cells, and what do they mean?"
- Some mutations have FDA-approved targeted treatments
- Ask: "Are there targeted therapies available for my specific mutations?"
ABOUT MARGINS & COMPLETENESS
-
"Were the surgical margins clear, and what does that mean?"
- Clear margins mean cancer wasn't found at the edges of removed tissue (usually good)
- Positive margins may mean additional treatment is needed
- Ask what the next steps are based on your margin status
-
"Was all the cancer removed, or is there more to treat?"
- This determines whether you need additional surgery, radiation, or systemic therapy
ABOUT TREATMENT PLANNING
-
"Based on all these findings, what treatment options do you recommend for me?"
- Ask your doctor to explain the reasoning behind their recommendation
- Ask about alternative approaches and why one is preferred
-
"Are there clinical trials that match my specific cancer profile?"
- Your biomarkers and stage may qualify you for trials with newer treatments
- Ask your doctor or visit ClinicalTrials.gov to search
-
"What follow-up testing will I need, and how often?"
- Ask about surveillance plans (imaging, blood work, physical exams)
- Understanding your monitoring schedule helps you stay proactive
ABOUT WHAT YOU DON'T UNDERSTAND
-
"Can you explain [specific term] in simpler language?"
- Don't hesitate to ask for clarification on any medical jargon
- Ask your doctor to draw diagrams or use analogies if helpful
-
"Can I get a copy of my full pathology report to review at home?"
- Having the actual report helps you prepare questions and share with other doctors
- You have the right to your [ID removed]
TIPS FOR YOUR APPOINTMENT:
- Bring a notebook or recording device (with permission) to capture details
- Bring a trusted person to help you listen and take notes
- Ask for written summaries of key findings and recommendations
- Request resources from organizations like the American Cancer Society or NCCN for your specific cancer type
- Don't rush—ask your doctor to slow down if needed
According to the American Cancer Society and NCCN Guidelines, understanding your pathology report is essential for informed decision-making about your treatment plan. Your pathologist's findings directly guide which therapies your oncologist will recommend.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with diagnosis for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2